CDMO Avid Bioservices Inc

Price (delayed)

$9.35

Market cap

$594.48M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.23

Enterprise value

$762.76M

Avid Bioservices is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biopharmaceutical drug substances derived from mammalian cell culture. The company provides a ...

Highlights
Avid Bioservices's quick ratio has soared by 189% YoY
CDMO's revenue is down by 6% year-on-year but it is up by 2.3% since the previous quarter
CDMO's gross profit has dropped by 77% year-on-year and by 28% since the previous quarter
Avid Bioservices's gross margin has plunged by 75% YoY and by 31% from the previous quarter

Key stats

What are the main financial stats of CDMO
Market
Shares outstanding
63.58M
Market cap
$594.48M
Enterprise value
$762.76M
Valuations
Price to book (P/B)
9.75
Price to sales (P/S)
4.22
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.45
Earnings
Revenue
$139.91M
EBIT
-$22.59M
EBITDA
-$11.48M
Free cash flow
-$20.85M
Per share
EPS
-$2.23
Free cash flow per share
-$0.33
Book value per share
$0.96
Revenue per share
$2.21
TBVPS
$5.33
Balance sheet
Total assets
$336.56M
Total liabilities
$275.67M
Debt
$206.38M
Equity
$60.89M
Working capital
$33.44M
Liquidity
Debt to equity
3.39
Current ratio
1.47
Quick ratio
0.78
Net debt/EBITDA
-14.66
Margins
EBITDA margin
-8.2%
Gross margin
5.2%
Net margin
-100.6%
Operating margin
-13.3%
Efficiency
Return on assets
-33.3%
Return on equity
-91.6%
Return on invested capital
-5.5%
Return on capital employed
-8.5%
Return on sales
-16.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CDMO stock price

How has the Avid Bioservices stock price performed over time
Intraday
-2.5%
1 week
-1.89%
1 month
24.01%
1 year
-32.78%
YTD
43.85%
QTD
30.95%

Financial performance

How have Avid Bioservices's revenue and profit performed over time
Revenue
$139.91M
Gross profit
$7.32M
Operating income
-$18.68M
Net income
-$140.75M
Gross margin
5.2%
Net margin
-100.6%
CDMO's gross profit has dropped by 77% year-on-year and by 28% since the previous quarter
Avid Bioservices's gross margin has plunged by 75% YoY and by 31% from the previous quarter
The operating income has contracted by 13% from the previous quarter
The operating margin has declined by 10% since the previous quarter

Growth

What is Avid Bioservices's growth rate over time

Valuation

What is Avid Bioservices stock price valuation
P/E
N/A
P/B
9.75
P/S
4.22
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.45
CDMO's price to book (P/B) is 132% more than its last 4 quarters average of 4.2 but 8% less than its 5-year quarterly average of 10.6
Avid Bioservices's equity has shrunk by 68% YoY and by 66% QoQ
CDMO's P/S is 45% below its 5-year quarterly average of 7.7 but 14% above its last 4 quarters average of 3.7
CDMO's revenue is down by 6% year-on-year but it is up by 2.3% since the previous quarter

Efficiency

How efficient is Avid Bioservices business performance
The company's return on sales fell by 23% QoQ
Avid Bioservices's return on invested capital has decreased by 22% QoQ

Dividends

What is CDMO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CDMO.

Financial health

How did Avid Bioservices financials performed over time
The total assets is 22% greater than the total liabilities
Avid Bioservices's quick ratio has soared by 189% YoY
CDMO's current ratio has surged by 183% year-on-year
Avid Bioservices's equity has shrunk by 68% YoY and by 66% QoQ
The company's debt rose by 9% YoY and by 6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.